A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors
IK930-001
Phase 1 other active
Quick answer
A Phase 1 study to evaluate IK-930 in subjects with advanced solid tumors for Advanced Solid Tumors is a Phase 1 program (other) at Ology Bioservices Ireland LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Ology Bioservices Ireland LTD
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active